🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This is a multicenter, randomized, double-blind, parallel group study to co...
Status
Terminated
Location
First Hospital of Shanxi Medical University
Start Date
2018-11-16
Trial ID
NCT03670888
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This phase II trial tests how well nemtabrutinib works with rituximab for t...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-22
Trial ID
NCT06572618
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This phase II trial studies how well vorinostat and combination chemotherap...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-29
Trial ID
NCT04220008
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested
This phase I/II trial finds out the best dose, possible benefits and/or sid...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-10-13
Trial ID
NCT05025800
Treatments Being Tested
This phase II/III trial tests whether it is possible to decrease the chance...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-10-22
Trial ID
NCT03984448